ApprovalTrail

Drug · DIN 02421453

DONEPEZIL

No: cancelled before it was sold

Authorized, then cancelled before it was ever sold in Canada.

Status Cancelled Pre Market since August 19, 2022.
Drug Identification Number (DIN)
02421453
Company (DIN owner)
Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Donepezil N06DA02
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
DONEPEZIL HYDROCHLORIDE5 MG

Notices of Compliance

Health Canada approvals that name this DIN.

Other DINs named DONEPEZIL